Methods and compositions for modulating the immune system and uses thereof
    3.
    发明申请
    Methods and compositions for modulating the immune system and uses thereof 审中-公开
    用于调节免疫系统的方法和组合物及其用途

    公开(公告)号:US20080089950A1

    公开(公告)日:2008-04-17

    申请号:US11800420

    申请日:2007-05-04

    摘要: The present invention provides methods of preventing, treating or ameliorating one or more symptoms of disorders in which modulation of a subject's immune system is beneficial utilizing a lymphoid tissue inducing agent and an immunomodulatory agent. In particular, the present invention provides methods of preventing, treating or ameliorating a proliferative disorder, an infectious disease, a cardiovascular disease, an autoimmune disorder, or an inflammatory disorder or one or more symptoms thereof comprising administering to a subject in need thereof one or more lymphoid tissue inducing agents and one or immunomodulatory agents. The present invention also provides compositions and articles of manufacture for use in preventing, treating or ameliorating one or more symptoms associated with disorders in which modulation of a subject's immune system is beneficial, including, but not limited to proliferative disorders, infectious diseases, cardiovascular diseases, autoimmune disorders and inflammatory disorders. The present invention further provides methods for screening and identifying lymphoid tissue inducing agents and/or immunomodulatory agents.

    摘要翻译: 本发明提供了使用淋巴组织诱导剂和免疫调节剂来预防,治疗或改善其中调节受试者免疫系统有益的一种或多种疾病症状的方法。 特别地,本发明提供预防,治疗或改善增殖性疾病,感染性疾病,心血管疾病,自身免疫性疾病或炎症性疾病或其一种或多种症状的方法,其包括向有需要的受试者施用一种或多种 更多的淋巴组织诱导剂和一种或免疫调节剂。 本发明还提供用于预防,治疗或改善与调节受试者的免疫系统有益的疾病相关的一种或多种症状的组合物和制品,其包括但不限于增殖性疾病,感染性疾病,心血管疾病 ,自身免疫性疾病和炎症性疾病。 本发明还提供筛选和鉴定淋巴组织诱导剂和/或免疫调节剂的方法。

    Bcrm-1 genes and uses thereof
    4.
    发明申请
    Bcrm-1 genes and uses thereof 审中-公开
    Bcrm-1基因及其用途

    公开(公告)号:US20070092877A1

    公开(公告)日:2007-04-26

    申请号:US10542558

    申请日:2004-02-24

    摘要: A polypeptide capable of conferring multidrug-resistance on a cell is disclosed. Also disclosed are nucleic acids encoding the polypeptide, expression vectors, trasformant host cell lines expressing the polypeptide, and antibodies binding to the polypeptide. Screening, diagnostic and treatment methods using the above polypeptide, nucleic acids, antibodies and host cell lines are also within the scope of this invention.

    摘要翻译: 公开了能够赋予细胞多药耐药性的多肽。 还公开了编码多肽,表达载体,表达多肽的trasformant宿主细胞系和与多肽结合的抗体的核酸。 使用上述多肽,核酸,抗体和宿主细胞系的筛选,诊断和治疗方法也在本发明的范围内。

    Mrp3 genes and uses thereof
    7.
    发明申请
    Mrp3 genes and uses thereof 审中-公开
    Mrp3基因及其用途

    公开(公告)号:US20070015913A1

    公开(公告)日:2007-01-18

    申请号:US10542128

    申请日:2004-02-24

    摘要: A nucleic acid capable of driving the expression of a reporter gene in a cancer cell line is disclosed. A polypeptide able to confer multidrug-resistance on a cell is disclosed. Also disclosed are nucleic acids encoding the polypeptide, expression vectors, transformant host cell lines expressing the polypeptide, and antibodies binding to the polypeptide. Screening, diagnostic and treatment methods using the above polypeptide, nucleic acids, antibodies and host cell lines are also within the scope of this invention.

    摘要翻译: 公开了能够驱动癌细胞系中报道基因表达的核酸。 公开了能够赋予细胞多药耐药性的多肽。 还公开了编码多肽,表达载体,表达多肽的转化体宿主细胞系和与多肽结合的抗体的核酸。 使用上述多肽,核酸,抗体和宿主细胞系的筛选,诊断和治疗方法也在本发明的范围内。